Mirna Therapeutics

Biotechnology research and development company focused on miRNA-directed oncology therapies.

Launch date

2007

Employees

Market cap

Enterprise valuation

Austin Texas (HQ)

Date	Investors	Amount	Round
Dec 2009	N/A	$5.0m	Grant
Jun 2010	N/A	$10.3m	Grant
Aug 2011	N/A	$1.5m	Series B
Oct 2012	New Enterprise Associates Correlation Ventures PTV Healthcare Capital Osage University Partners Sofinnova Ventures	$34.5m	Series C
Apr 2015	New Enterprise Associates Correlation Ventures Morningside Group Sante Ventures Rock Springs Capital Celgene Baxter Ventures Osage University Partners Eastern Capital Sofinnova Ventures	$41.8m	Series D
Oct 2015	Pfizer Ventures	$16.8m	Post IPO Equity
Oct 2015	N/A	N/A	IPO
Total Funding		€84.6m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Mirna Therapeutics